F3+R Inc.

F3+R Inc.

Founded in 2018 by Tim L. and Terry Johnston, F3+R Inc. (faith, family, fellowship and research) has raised more than $1 million for the Timothy A. Johnston Fund for Precision Medicine Research at the IU Simon Comprehensive Cancer Center.

Give Now

When their son, Tim A. Johnston of Westfield — an otherwise healthy 38-year-old husband and father — was diagnosed with Stage IV lung cancer, the Johnstons founded F3+R Inc. so that more families could benefit from the types of treatment their son was receiving. The Timothy A. Johnston Fund for Precision Medicine Research is restricted to research focused on identifying ways to treat cancer based on the way the individual patient’s specific tumor is wired. Tim’s remission has been made possible by these “precision” therapies, which are available for various types of cancer, including lung, breast, pancreatic, ovarian, colon and more.

In Dr. Larry Einhorn’s words, “Tim achieved a complete remission lasting more than five years with his first molecular targeted drug for his ALK translocation, Alectinib, for his metastatic Stage IV lung cancer. He is back in complete remission with his second ALK inhibitor, Brigatinib, for more than two years now. We have every hope and confidence that his remission this time will last even longer than with his prior Alectinib.”

F3+R’s goal is to fund research that broadens the impact of the Precision Genomics Program by identifying new targets for precision drugs. The more targets that researchers can identify, the more patients they can help.

To learn more about F3+R, please click here.